These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4329897)

  • 41. [Hemagglutination by avian smallpox virus].
    VIEUCHANGE J
    Ann Inst Pasteur (Paris); 1952 Dec; 83(6):834. PubMed ID: 13017201
    [No Abstract]   [Full Text] [Related]  

  • 42. [Animal experimental studies on various smallpox vaccines in a cowpox challenge experiment on white mice].
    Herrlich A; Epp C; Mayr A
    Z Immunitatsforsch Allerg Klin Immunol; 1968 May; 135(3):237-45. PubMed ID: 4301159
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hemagglutination and the virus of avian smallpox].
    VIEUCHANGE J; LAVAL E
    Ann Inst Pasteur (Paris); 1952 Feb; 82(2):186-93. PubMed ID: 14952934
    [No Abstract]   [Full Text] [Related]  

  • 44. The immunity to vaccina virus of Japanese people of different age groups: serum antibody titre and local skin reaction at the site of vaccination.
    Kitaoka M; Nishimura C; Kimura M
    Prog Immunobiol Stand; 1970; 4():683-91. PubMed ID: 5482206
    [No Abstract]   [Full Text] [Related]  

  • 45. The persistence of neutralizing antibodies after revaccination against smallpox.
    el-Ad B; Roth Y; Winder A; Tochner Z; Lublin-Tennenbaum T; Katz E; Schwartz T
    J Infect Dis; 1990 Mar; 161(3):446-8. PubMed ID: 2155973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies of smallpox antibody levels of sera from samples of the vaccinated adult population of Madras.
    DOWNIE AW; HOBDAY TL; ST VINCENT L; KEMPE CH
    Bull World Health Organ; 1961; 25(1):55-61. PubMed ID: 13887635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relation between the neutralizing and haemagglutination-inhibiting antibodies in smallpox.
    Sarkar JK; Chatterjee SN; Mitra AC; Mondal A
    Indian J Med Res; 1969 Jan; 57(1):8-12. PubMed ID: 5770847
    [No Abstract]   [Full Text] [Related]  

  • 48. Isolation and properties of the causal agent of a new variola-like disease (monkeypox) in man.
    Marennikova SS; Seluhina EM; Mal'ceva NN; Cimiskjan KL; Macevic GR
    Bull World Health Organ; 1972; 46(5):599-611. PubMed ID: 4340219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haemagglutinating activity of variola virus.
    Shafikova RA
    Acta Virol; 1969 Mar; 13(2):157. PubMed ID: 4389045
    [No Abstract]   [Full Text] [Related]  

  • 50. [Morphologic and serologic evaluation of the reaction to smallpox revaccination with special reference to virus neutralizing antibodies].
    Herrlich A; Adldinger H; Möbest H
    Dtsch Med Wochenschr; 1965 Dec; 90(50):2225-9. PubMed ID: 4285228
    [No Abstract]   [Full Text] [Related]  

  • 51. Application of the fluorescent antibodies method for rapid diagnosis caused of diseases by pox viruses.
    Maltseva MN; Nishanov RA
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(2):214-20. PubMed ID: 184205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. THE IMMUNOLOGIC RELATIONSHIP OF VARIOLA AND VACCINIA VIRUSES. A-UTILIZING HEMAGGLUTINATION INHIBITION TESTS.
    PATORIA NK; JUNNARKAR RV
    Indian J Med Sci; 1963 Nov; 17():876-81. PubMed ID: 14081878
    [No Abstract]   [Full Text] [Related]  

  • 53. [Experiments on the challenge of the antivaccinial transfer immunity of cell cultures by infection with variola virus. (Evaluation of the antivariola potency of smallpox vaccines)].
    Stickl H
    Zentralbl Bakteriol Orig; 1968; 208(4):473-85. PubMed ID: 4329545
    [No Abstract]   [Full Text] [Related]  

  • 54. Further studies with precipitation in gel test in diagnosis of smallpox. I. Studies on detection of antibodies in sera by pig test.
    Rao AR; Savithri Sukumar M; Kamalakshi S; Paramasivam TV; Ramakrishnan S
    Indian J Med Res; 1972 Sep; 60(9):1254-60. PubMed ID: 4350577
    [No Abstract]   [Full Text] [Related]  

  • 55. Haemagglutination through vaccinia virus; inhibition after revaccination.
    COLLIER WA; VAN THIEL WJ
    Doc Neerl Indones Morbis Trop; 1949 Sep; 1(3):234-44. PubMed ID: 15393602
    [No Abstract]   [Full Text] [Related]  

  • 56. Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6.
    Aldaz-Carroll L; Xiao Y; Whitbeck JC; de Leon MP; Lou H; Kim M; Yu J; Reinherz EL; Isaacs SN; Eisenberg RJ; Cohen GH
    J Virol; 2007 Aug; 81(15):8131-9. PubMed ID: 17522205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioterrorism. Smallpox vaccinations: how much protection remains?
    Cohen J
    Science; 2001 Nov; 294(5544):985. PubMed ID: 11691969
    [No Abstract]   [Full Text] [Related]  

  • 58. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.
    Rosengard AM; Liu Y; Nie Z; Jimenez R
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8808-13. PubMed ID: 12034872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Age differences in the immunobiological reaction in infants in the 1st year of life vaccinated against smallpox].
    Denisov GM
    Vopr Okhr Materin Det; 1967 Mar; 12(5):43-7. PubMed ID: 5610610
    [No Abstract]   [Full Text] [Related]  

  • 60. The hemagglutination inhibition test for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status.
    Lennette EH; Schmidt NJ; Magoffin RL
    J Immunol; 1967 Oct; 99(4):785-93. PubMed ID: 4860926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.